RSV is a major cause of lower respiratory tract infections in infants and young children. Preventive options have expanded, but care for established RSV pneumonia remains largely supportive. Previous research has shown that RSV disrupts how the lungs process fats and weakens some of the antioxidant defenses that normally protect airway cells. These changes can leave cell membranes vulnerable to oxidative damage. Earlier experimental studies suggested that Ganjie decoction, made from balloon flower and Chinese licorice roots, could reduce inflammation and alter lipid metabolism. The researchers wanted to determine whether ferroptosis contributes to RSV-related lung injury and whether the formula could limit that damage.
A study (DOI: 10.48130/targetome-0026-0062) published in Targetome on 10 November 2026 by Jinjun Shan's team, Nanjing University of Chinese Medicine, reports that the formula reduced lung injury in RSV-infected mice and restored several components of a cellular defense system that limits membrane lipid oxidation.
The researchers compared two doses of Ganjie decoction with ribavirin and with untreated infection in a mouse model of RSV pneumonia. Microscopic examination showed that the formula reduced thickening of the walls between air sacs, bleeding and the accumulation of inflammatory cells, with more pronounced improvements at the higher dose. Measurements in fluid collected from the lungs also showed lower levels of three inflammatory signaling molecules. To examine how infection affected membrane fats, the team used mass spectrometry to profile lipids in lung tissue and blood serum. RSV increased several phosphatidylethanolamines containing polyunsaturated fatty acids, which are particularly susceptible to oxidation. The formula lowered the levels of selected lipids in this group. Fluorescence imaging also showed less accumulation of ferrous iron and less lipid oxidation in treated lungs, while biochemical assays indicated an improvement in the balance between reduced and oxidized glutathione, a measure of antioxidant capacity. In separate experiments, the researchers used ferrostatin-1, a compound that inhibits ferroptosis. It reduced lung damage and inflammation in mice and reduced cell death in two human lung epithelial cell lines. Electron microscopy showed that it also limited damage to mitochondria in one of the cell lines. In mice treated with the decoction, protein assays and imaging showed that more of the antioxidant regulator NRF2 was present in cell nuclei and that levels of SLC7A11 and GPX4, two proteins that help protect against lipid oxidation, recovered. Finally, the team analyzed two public pediatric datasets. GPX4 expression was lower in blood from children with acute RSV than in healthy controls and lower in nasal samples taken during acute illness than in samples taken from the same children during recovery.
Together, the mouse and cell experiments suggest that ferroptosis contributes to lung injury during RSV pneumonia and that Ganjie decoction helps preserve the defenses that protect cell membranes. The pediatric findings provide an initial clue that one component of this defense system also changes during human infection. Further studies will need to establish whether the pathway is required for the formula's protective effect and whether the benefits observed in mice translate to patients.
###
References
DOI
10.48130/targetome-0026-0062
Original Source URL
https://doi.org/10.48130/targetome-0026-0062
Funding information
This work was supported by the National Natural Science Foundation of China (Grant Nos 82174098 and 81774156); the National Key R&D Program of China (2023YFC2308200); the National Key Laboratory of Traditional Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacturing Technology Research Innovation Project (No. NZYSKL240106); Excellent Scientific and Technological Innovation Team of Jiangsu Universities, High-level Chinese Medicine Key Discipline Construction Project of National Administration of Traditional Chinese Medicine, Open Research Project of Jiangsu Provincial Center for Traditional Chinese Medicine Epidemic Disease Research (JSYB2024KF28); Nanjing University of Chinese Medicine Talent Program for Research Platforms, the Key Research Project of Jiangsu Provincial Academy of Chinese Medicine Schools (LPZD2025012); and Postgraduate Research and Practice Innovation Program of Jiangsu Province (26CXJH3751).
About Targetome
Targetome refers to the complete collection of molecular targets (e.g., proteins, RNA or DNA) that interact with and mediate the effect of a specific biomolecule, such as a drug, toxin, metabolites, transcription factor or microRNA, within a biological system. Targetome (Print ISSN 3071-0596; e-ISSN 3070-3808) is an open access journal publishing rigorously peer-reviewed original research articles, reviews, break-through methods, and perspectives that advance our understanding, identification and validation of molecular targets for new drug development.